# Establishment of accurate estimation equations for area under the concentration curves using simultaneous limited sampling for extended-release tacrolimus and mycophenolic acid in kidney transplant recipients

**Authors:** Kyoko Minamisono, Toshimasa Nakao, Takehiro Ohyama, Sho Nishida, Hajime Sasaki, Takayuki Hirose, Kiyohiko Hotta, Makiko Mieno, Daiki Iwami

PMC · DOI: 10.3389/fimmu.2026.1710261 · 2026-02-03

## TL;DR

Researchers developed equations to estimate drug exposure in kidney transplant patients using limited blood samples, improving clinical efficiency.

## Contribution

The study introduces reliable limited sampling equations for tacrolimus and mycophenolic acid in kidney transplant recipients.

## Key findings

- Four equations showed strong correlations with actual AUC (R² > 0.95).
- C0-C1-C3-C6 was identified as the most reliable equation for both drugs.
- The equations can be used in outpatient settings to reduce time and cost.

## Abstract

This study aimed to develop a limited sampling strategy (LSS) and predictive equations to accurately estimate the areas under the concentration-time curves (AUC) of extended-release tacrolimus (TAC-ER) and mycophenolic acid (MPA).

A retrospective analysis of Japanese kidney transplant recipients yielded 90 TAC-ER AUC0-24 (23 patients) and 80 MPA AUC0-12 (29 patients) datasets, which were randomly split into learning and validation datasets. Training datasets were used to generate the LSS model equations based on multiple linear regression analysis, and the coefficient of determination (R2) was used to assess the goodness of fit of regression models. Validation datasets applied the selected training equations to compute error indices, Passing-Bablok’s Kendall’s τ, and Bland–Altman limits of agreement, thereby assessing predictive bias, accuracy, and precision.

Four equations (C0-C1-C6, C0-C1-C2-C6, C0-C1-C3-C6, C0-C1-C4-C6) showed strong correlations with the actual AUC (R² > 0.95), with the validation identifying C0-C1-C3-C6 as the most reliable for both TAC-ER and MPA. This study demonstrated that LSS using C0-C1-C3-C6 reliably and accurately estimated both the actual TAC-ER AUC0-24 and MPA AUC0-12 simultaneously in kidney transplant recipients. These equations can be feasibly implemented in outpatient clinical settings to reduce time and cost.

## Linked entities

- **Chemicals:** tacrolimus (PubChem CID 445643), mycophenolic acid (PubChem CID 446541)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, UGT2B7 (UDP glucuronosyltransferase family 2 member B7) [NCBI Gene 7364] {aka UDPGT 2B7, UDPGT 2B9, UDPGT2B7, UDPGTH2, UDPGTh-2, UGT2B9}
- **Diseases:** HS (MESH:C567159), opportunistic infections (MESH:D009894), renal toxicity (MESH:D007674), MPA (MESH:D011015), infections (MESH:D007239)
- **Chemicals:** C4 (MESH:C058899), glucuronide (MESH:D020719), MMF (MESH:D009173), ER (MESH:D004871), TAC (MESH:D016559), C0-C1-C3-C6 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12909250/full.md

---
Source: https://tomesphere.com/paper/PMC12909250